HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 106 filers reported holding HERON THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.14 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $36,750 | +26.4% | 10,500 | 0.0% | 0.00% | 0.0% |
Q1 2024 | $29,085 | +62.9% | 10,500 | 0.0% | 0.00% | +100.0% |
Q4 2023 | $17,850 | +65.0% | 10,500 | 0.0% | 0.00% | 0.0% |
Q3 2023 | $10,815 | -13.6% | 10,500 | -2.7% | 0.00% | 0.0% |
Q2 2023 | $12,517 | -23.2% | 10,790 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $16,293 | -37.9% | 10,790 | +2.8% | 0.00% | -50.0% |
Q4 2022 | $26,250 | -89.9% | 10,500 | -0.8% | 0.00% | -94.1% |
Q1 2019 | $260,000 | -5.8% | 10,585 | -0.0% | 0.03% | -24.4% |
Q4 2018 | $276,000 | -15.6% | 10,590 | +0.9% | 0.04% | -22.4% |
Q3 2018 | $327,000 | -20.2% | 10,500 | 0.0% | 0.06% | -23.7% |
Q2 2018 | $410,000 | +41.4% | 10,500 | 0.0% | 0.08% | +35.7% |
Q1 2018 | $290,000 | +52.6% | 10,500 | 0.0% | 0.06% | +55.6% |
Q4 2017 | $190,000 | +5.6% | 10,500 | 0.0% | 0.04% | -5.3% |
Q3 2017 | $180,000 | +24.1% | 10,500 | 0.0% | 0.04% | +15.2% |
Q2 2017 | $145,000 | -9.9% | 10,500 | 0.0% | 0.03% | -10.8% |
Q1 2017 | $161,000 | – | 10,500 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG KEVIN | 37,999 | $706,000 | 24.13% |
TANG CAPITAL MANAGEMENT LLC | 5,744,096 | $106,783,000 | 14.43% |
BRIDGER MANAGEMENT, LLC | 2,846,555 | $52,917,000 | 4.15% |
First Light Asset Management, LLC | 1,098,723 | $20,425,000 | 2.84% |
Broadfin Capital, LLC | 657,998 | $12,232,000 | 2.66% |
HIGHLAND CAPITAL MANAGEMENT LP | 1,606,942 | $29,873,000 | 1.75% |
EMORY UNIVERSITY | 129,020 | $2,398,000 | 1.69% |
Mesirow Financial Investment Management, Inc. | 24,112 | $430,000 | 1.57% |
Congress Park Capital LLC | 109,665 | $1,945,000 | 1.54% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 830,821 | $15,445,000 | 1.52% |